Filter News
Area of Research
- (-) Biology and Environment (16)
- (-) Materials for Computing (2)
- (-) Neutron Science (11)
- Biological Systems (1)
- Clean Energy (6)
- Computational Biology (2)
- Computational Engineering (1)
- Fusion and Fission (1)
- Isotopes (5)
- Materials (7)
- National Security (2)
- Nuclear Science and Technology (2)
- Supercomputing (17)
News Topics
- (-) Biomedical (28)
- 3-D Printing/Advanced Manufacturing (19)
- Advanced Reactors (2)
- Artificial Intelligence (14)
- Big Data (10)
- Bioenergy (50)
- Biology (75)
- Biotechnology (13)
- Buildings (2)
- Chemical Sciences (17)
- Clean Water (13)
- Climate Change (41)
- Composites (6)
- Computer Science (35)
- Coronavirus (21)
- Critical Materials (1)
- Cybersecurity (1)
- Decarbonization (21)
- Energy Storage (17)
- Environment (98)
- Exascale Computing (4)
- Fossil Energy (1)
- Frontier (4)
- Fusion (1)
- Grid (3)
- High-Performance Computing (22)
- Hydropower (8)
- Isotopes (3)
- Machine Learning (10)
- Materials (35)
- Materials Science (40)
- Mathematics (3)
- Mercury (7)
- Microscopy (17)
- Molten Salt (1)
- Nanotechnology (24)
- National Security (6)
- Net Zero (2)
- Neutron Science (101)
- Nuclear Energy (4)
- Partnerships (5)
- Physics (11)
- Polymers (9)
- Quantum Computing (1)
- Quantum Science (9)
- Renewable Energy (1)
- Security (4)
- Simulation (14)
- Space Exploration (3)
- Summit (15)
- Sustainable Energy (36)
- Transformational Challenge Reactor (1)
- Transportation (12)
Media Contacts
![ATOM logo](/sites/default/files/styles/list_page_thumbnail/public/2021-03/ATOM_Logo_small.png?h=8f9cfe54&itok=Qpezfk8V)
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
![Neutron scattering experiments show electric charges, shown in red, blue and grey, in the SARS-CoV-2 main protease site where telaprevir binds to the structure. The experiments provide critical data for the design of small-molecule drugs to treat COVID-19. Credit: Jill Hemman and Michelle Lehman/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-03/after_transprent_background-wFill.png?h=c71d0c67&itok=jGFt_Ggj)
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
Oak Ridge National Laboratory and collaborators have discovered that signaling molecules known to trigger symbiosis between plants and soil bacteria are also used by almost all fungi as chemical signals to communicate with each other.
![coronavirus](/sites/default/files/styles/list_page_thumbnail/public/2020-11/coronavirus_top10%20%28002%29.png?h=997b30da&itok=7I6TjG_l)
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.
![ORNL assisted in investigating proteins called porins, one shown in red, which are found in the protective outer membrane of certain disease-causing bacteria and tether the membrane to the cell wall. Credit: Hyea (Sunny) Hwang/Georgia Tech and ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2020-11/Biology-gram-negative_0.jpg?h=ced0ee1c&itok=mTOudglI)
Scientists from Oak Ridge National Laboratory used high-performance computing to create protein models that helped reveal how the outer membrane is tethered to the cell membrane in certain bacteria.
![The first neutron structure of the SARS-CoV-2 main protease enzyme revealed unexpected electrical charges in the amino acids cysteine (negative) and histidine (positive), providing key data about the virus’s replication. Credit: Jill Hemman/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2020-10/20-G01620_Protease_PR_proof2_0.jpg?h=3e3883a3&itok=XB_ZEDFQ)
To better understand how the novel coronavirus behaves and how it can be stopped, scientists have completed a three-dimensional map that reveals the location of every atom in an enzyme molecule critical to SARS-CoV-2 reproduction.
![Shown here is an on-chip carbonized electrode microstructure from a scanning electron microscope. Credit: ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2020-10/Lavrik%20Story%20Tip_0.jpg?h=33192216&itok=nNMwVUtU)
Scientists at Oak Ridge National Laboratory and the University of Tennessee designed and demonstrated a method to make carbon-based materials that can be used as electrodes compatible with a specific semiconductor circuitry.
![ORNL researchers and energy storage startup Sparkz have developed a cobalt-free cathode material for use in lithium-ion batteries Credit: Ilias Belharouak/Oak Ridge National Laboratory, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2020-10/cobalt-sparkz_0.jpg?h=cd715a88&itok=vTU2FKUY)
Four research teams from the Department of Energy’s Oak Ridge National Laboratory and their technologies have received 2020 R&D 100 Awards.
![Enzyme activity during organophosphate poisoning](/sites/default/files/styles/list_page_thumbnail/public/2020-08/anecdote1_0.png?h=d1cb525d&itok=wpYYilBI)
Pick your poison. It can be deadly for good reasons such as protecting crops from harmful insects or fighting parasite infection as medicine — or for evil as a weapon for bioterrorism. Or, in extremely diluted amounts, it can be used to enhance beauty.
![Analyses of lung fluid cells from COVID-19 patients conducted on the nation’s fastest supercomputer point to gene expression patterns that may explain the runaway symptoms produced by the body’s response to SARS-CoV-2. Credit: Jason B. Smith/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2020-07/cells%20200%5B1%5D.png?h=b95f6d72&itok=V2OxqL5l)
A team led by Dan Jacobson of Oak Ridge National Laboratory used the Summit supercomputer at ORNL to analyze genes from cells in the lung fluid of nine COVID-19 patients compared with 40 control patients.